Georgetown's Office of Technology Commercialization

So fortunate to live near Washington DC where I get to attend events showcasing new technologies and highlighting emerging leaders in the innovation ecosystem. Last night Andrew Ray and Morgan, Lewis & Bockius LLP hosted Georgetown University’s Office of Technology Commercialization and their launch of the Gap Fund and Georgetown Technology Ventures. Sincerely humbled and inspired by John F. Crowley, Norman Beauchamp, and Tatiana Litvin-Vechnyak sharing their personal stories and their missions around the work they’re doing to combat Muscular Dystrophy, Alzheimer’s, and a host of other diseases that tragically, eventually touch all of us. It isn’t hyperbole to refer to all of them as heroes in the truest sense of the word. Write this down: Ten years from now some of the great breakthroughs in treatments and cures will have come out of what Georgetown University is building under the guidance, conviction, and determination of leaders like John, Norman, and Tatiana.

Technology Spotlight: Advancing Metabolic Disorder Treatment with a Natural Protein 🧬   Georgetown University researchers have discovered Fibroblast Growth Factor Binding Protein 3 (FGFBP3), a natural protein that could be a potential treatment for diabetes, obesity, and other related metabolic diseases by lowering blood glucose levels.    How it Works: 🩸The therapy utilizes fibroblast growth factor binding protein 3 (FGFBP3), which interacts with fibroblast growth factors (FGFs) to help regulate metabolism. Preclinical studies show that FGFBP3 effectively lowers blood glucose levels, reduces fat accumulation, and supports weight management.   Benefits: - Targeted Glucose Management: Specifically lowers blood glucose levels, providing a focused approach for diabetic patients. - Reduced Side Effects: May present fewer side effects compared to some conventional diabetes medications. - Fat Accumulation Reversal: Aids in reversing fat accumulation and supporting weight reduction. Market Application: 💊 Drug Development: Potential use in drug treatments for metabolic syndrome disorders such as fatty liver disease and type 2 diabetes. 💉Biotechnology: Applications in developing new diagnostics and treatments for challenging metabolic disorders.   We invite you to learn more about this promising technology that could enhance treatment options for metabolic disorders. IP Protected, Available for Licensing. Learn more: [https://lnkd.in/eukkSvG6] Interested in bringing this technology to market? Contact us for licensing details and partnership opportunities! [https://otc.georgetown.edu] #MetabolicHealth #DiabetesTreatment #Biotechnology #ObesityResearch #MedicalInnovation

Exciting opportunity for Maryland's innovative life science and technology companies! TEDCO's SBIR/STTR Proposal Lab is now accepting applications. This program offers expert guidance to help companies secure up to $305,000 in non-dilutive Phase I funding from the NSF. Key highlights: • Tailored for Maryland companies, including those in Frederick County • Hands-on training in proposal writing and review • Decades of experience in winning SBIR/STTR grants • Limited spots available - apply by December 13th • Weekly Office Hours for Q&ADon't miss this chance to transform your innovation into federal funding success! Learn more: [https://lnkd.in/evA_wbS]

Did you know the whole body #CT scanner, #Allegra, & the #HPV vaccine all were developed by innovators at Georgetown University ? The university is one of many research engines near #MontgomeryCountyMD whose spinouts can create jobs in the County with support from Montgomery County Government and others in the ecosystem.

🚀 Transforming Tech Transfer: Georgetown's Innovative Internship Journey   We're thrilled to share an insightful interview with our VP, Tatiana Litvin-Vechnyak, about the transformative Technology Commercialization Internship Program at Georgetown University. Our internship program is designed to cultivate the next generation of tech transfer professionals through a comprehensive two-semester experience focused on technology evaluation and marketing. The interns have the opportunity to gain invaluable skills and real-world experience while contributing to innovative projects alongside faculty researchers.   We invite you to read the full story to learn more about how we're shaping the future of technology transfer: [https://lnkd.in/eWjGXn95]   Interested in joining our next cohort? Find out more about the internship and be part of this exciting journey! 🌟 [https://lnkd.in/eMuWE7DB]   #TechTransfer #Innovation #GeorgetownUniversity

🚀 Celebrating Innovation: Georgetown's Entrepreneurial Ecosystem Shines Bright! 🌟 On Wednesday evening, the Georgetown University community attended an extraordinary reception that brought together faculty innovators and entrepreneurs, alumni and students, ecosystem leaders, and investors to celebrate the success of our Gap Fund and the launch of Georgetown Tech Ventures.  The event featured inspiring speeches from John F. Crowley, Norman Beauchamp, and Tatiana Litvin-Vechnyak. The future is bright for Georgetown and the DMV and our vision for the role we can play is ambitious! We envision Georgetown University as a recognized leader in the DMV region and nationwide, driving forward as a hub for groundbreaking research, innovative technologies, and entrepreneurial ventures. A heartfelt thank you to Andrew Ray of Morgan, Lewis & Bockius LLP and Mark Antonucci, and the Office of Advancement, as well as other GU and ML colleagues for making this event possible. We are proud to support Hoya inventors and entrepreneurs as they transform innovative ideas into real-world impact! Christon Hill, Robert Koenig, Spiros Dimolitsas

🌟Last Wednesday, Georgetown's OTC hosted an enlightening seminar as part of our Innovation 2 Impact (I2I) series, featuring Dr. Lydia McClure, CEO of Research Bridge Partners.    This event brought together researchers, inventors, and graduate students eager to learn how to attract early-stage investors for their entrepreneurial ventures.    Dr. McClure shared her extensive knowledge on navigating the pre-seed funding landscape, offering invaluable insights that empower attendees to transform their innovative ideas into viable businesses.   We proudly support our community in bridging the gap between research and real-world impact! 💡✨ #HoyaEntrepreneurs #Innovation2Impact #EarlyStageInvesting #GeorgetownInnovation

🎉 Exciting News! Georgetown Entrepreneurship has been honored with the Nasdaq Center of Entrepreneurial Excellence Award by the Global Consortium of Entrepreneurship Centers! 🏆 This award recognizes our program as one of the world’s best for advancing entrepreneurship through impactful outreach, innovative curriculum, and groundbreaking research. A huge thank you to our dedicated team, students, and community who make this excellence possible. Together, we’re shaping the future of entrepreneurship! Read more about the award here: https://lnkd.in/epsBAztE Jeff Reid Aveline Argo Benjamin Zimmerman Jacob Stiglitz Georgetown University McDonough School of Business

💡 Technology Spotlight: Small molecules to treat drug-resistant prostate cancer 💊 Georgetown University researchers have developed small molecule androgen receptor inhibitors for treating drug-resistant prostate cancers. 🏥 💉How it works: New compounds: A new class of patent-protected compounds inhibit androgen receptor signaling.   ➡️ Why It Matters: Prostate cancer is one of the most common cancers among men having an incidence rate of around 658 per 100,000 males.  Provides an alternative to current anti-androgens, potentially improving long-term outcomes.  Potentially applicable to other androgen receptor-positive cancers. More effective in treating some drug-resistant cancers. 📊 Market Applications: Potential for new cancer treatments. 💫 Join us in advancing cancer treatments and improving patient outcomes. IP Protected, Available for Licensing. Learn more: [https://lnkd.in/eVW99b6a] Interested in bringing this technology to market? Contact us for licensing details and partnership opportunities! [https://otc.georgetown.edu] #CancerTreatments #Pharma #AndrogenReceptorInhibitors

Virtual Startup Career Panel Tuesday, November 19th 5:00 - 6:00 pm https://lnkd.in/ehcic3Rs Are you curious about what it’s really like to work at a startup? Interested in exploring a career in the fast-paced world of entrepreneurship? Join Georgetown Entrepreneurship Initiative for an insightful Virtual Startup Career Panel, where you’ll hear firsthand from industry insiders, seasoned entrepreneurs, and alumni who have navigated diverse startup roles. During this one-hour session, our expert panelists will break down the essentials of startup life, offering invaluable advice on the skills and mindset needed to thrive in this space. Discover what startups are looking for, learn about the unique challenges and rewards of startup roles, and gain clarity on how to launch or advance your own startup career. Whether you’re considering founding your own venture, joining a growing startup, or simply exploring the possibilities, this event is a great opportunity to gain practical insights within Georgetown's entrepreneurial community. Don’t miss out on the chance to learn from and connect with those who’ve been in your shoes and are ready to guide you forward!